Roivant Sciences (ROIV)
Develops immunology medicines and delivery technologies through focused Vant subsidiaries.
$38.22
After hours0.00 (0.00%)
At close$38.22(−1.97%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 48 days
EPS estimate
−$0.41
Revenue estimate
$3.7M
Fiscal quarter
Q2 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.23−$0.29−$0.25−$0.20−$0.24−$0.28−$0.33Pending
Estimate−$0.25−$0.26−$0.25−$0.32−$0.30−$0.29−$0.30−$0.41
Surprise+9.0%−10.1%−0.8%+36.9%+19.9%+3.5%−10.1%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$9.0M$7.6M$2.2M$1.6M$2.0M$2.5M$1.4MPending
Estimate$5.0M$54.1M$7.3M$5.6M$5.1M$3.4M$2.1M$3.7M
Surprise+80.4%−86.0%−70.3%−72.0%−60.6%−26.2%−29.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Mar 2028 | −$0.24 | — | — |
| Dec 2027 | −$0.29 | — | — |
| Sep 2027 | −$0.31 | — | — |
| Jun 2027 | −$0.33 | — | — |
| Mar 2027 | −$0.35 | — | — |
| Dec 2026 | −$0.36 | — | — |
| Nov 2026 | −$0.41 | — | — |
| Aug 2026 | −$0.30 | −$0.33 | −10.1% |
| May 2026 | −$0.29 | −$0.28 | +3.5% |
| Feb 2026 | −$0.30 | −$0.24 | +19.9% |
| Nov 2025 | −$0.32 | −$0.20 | +36.9% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Jun 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Sep 2021 | — | — | — |
| Aug 2021 | — | — | — |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Mar 2028 | −$0.24 | — | — | $161.9M | — | — | — |
| Dec 2027 | −$0.29 | — | — | $107.6M | — | — | — |
| Sep 2027 | −$0.31 | — | — | $73.1M | — | — | — |
| Jun 2027 | −$0.33 | — | — | $52.8M | — | — | — |
| Mar 2027 | −$0.35 | — | — | $36.7M | — | — | — |
| Dec 2026 | −$0.36 | — | — | $12.3M | — | — | — |
| Nov 9, 2026 | −$0.41 | — | — | $3.7M | — | — | — |
| Aug 6, 2026 | −$0.30 | −$0.33 | −10.1% | $2.1M | $1.4M | −29.9% | +1.5% |
| May 20, 2026 | −$0.29 | −$0.28 | +3.5% | $3.4M | $2.5M | −26.2% | +14.9% |
| Feb 6, 2026 | −$0.30 | −$0.24 | +19.9% | $5.1M | $2.0M | −60.6% | +22.1% |
| Nov 10, 2025 | −$0.32 | −$0.20 | +36.9% | $5.6M | $1.6M | −72.0% | +2.7% |
| Aug 11, 2025 | |||||||
| May 29, 2025 | |||||||
| Feb 10, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 30, 2024 | |||||||
| Feb 13, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| Jun 28, 2023 | |||||||
| Feb 13, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| Jun 28, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Sep 21, 2021 | — | — | — | — | — | — | — |
| Aug 10, 2021 | — | — | — | — | — | — | — |